PASW (Ping An Biomedical Co) Liabilities-to-Assets : 0.34 (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PASW Ping An Biomedical Co Ltd PASW
17 GF Score
Price $0.12
! 3 Warning Signs
View Full Analysis

What is Ping An Biomedical Co Liabilities-to-Assets?

Ping An Biomedical Co PASW -6.49% 17 Liabilities-to-Assets is 0.34 as of Sep. 2025. GuruFocus rates PASW with a GF Score™ of 17/100. The stock has 3 warning signs investors should review.

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Ping An Biomedical Co's Total Liabilities for the quarter that ended in Sep. 2025 was $3.25 Mil. Ping An Biomedical Co's Total Assets for the quarter that ended in Sep. 2025 was $9.60 Mil. Therefore, Ping An Biomedical Co's Liabilities-to-Assets Ratio for the quarter that ended in Sep. 2025 was 0.34.


Ping An Biomedical Co  (NAS:PASW) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


Ping An Biomedical Co Liabilities-to-Assets Related Terms


Ping An Biomedical Co Liabilities-to-Assets Historical Data

* Premium members only.

The historical data trend for Ping An Biomedical Co's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ping An Biomedical Co Liabilities-to-Assets Chart

Ping An Biomedical Co Annual Data
Trend Sep21 Sep22 Sep23 Sep24 Sep25
Liabilities-to-Assets
1.03 0.94 1.07 1.13 0.34

Ping An Biomedical Co Semi-Annual Data
Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only 1.07 1.07 1.13 1.24 0.34

PASW vs DXYN, CULP, UFI: Liabilities-to-Assets Comparison

For the Textile Manufacturing subindustry, Ping An Biomedical Co's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ping An Biomedical Co Liabilities-to-Assets vs Manufacturing - Apparel & Accessories Industry

For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Ping An Biomedical Co's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Ping An Biomedical Co's Liabilities-to-Assets falls into.


PASW
17GF Score
Ping An Biomedical Co Ltd PASW
Liabilities-to-Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ping An Biomedical Co Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Ping An Biomedical Co's Liabilities-to-Assets Ratio for the fiscal year that ended in Sep. 2025 is calculated as:

Liabilities-to-Assets (A: Sep. 2025 )=Total Liabilities/Total Assets
=3.253/9.604
=0.34

Ping An Biomedical Co's Liabilities-to-Assets Ratio for the quarter that ended in Sep. 2025 is calculated as

Liabilities-to-Assets (Q: Sep. 2025 )=Total Liabilities/Total Assets
=3.253/9.604
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Liabilities-to-Assets →
What does a Liabilities-to-Assets of 0.34 mean?
Ping An Biomedical Co (PASW) has a Liabilities-to-Assets of 0.34 as of Sep. 2025. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on Ping An Biomedical Co and its competitors.
Is Ping An Biomedical Co's Liabilities-to-Assets too high?
Ping An Biomedical Co's current Liabilities-to-Assets is 0.34. Overall, Ping An Biomedical Co has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Ping An Biomedical Co's Liabilities-to-Assets compare to DXYN and CULP?
Ping An Biomedical Co's Liabilities-to-Assets of 0.34 can be compared against companies in the Manufacturing - Apparel & Accessories industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Liabilities-to-Assets for a Manufacturing - Apparel & Accessories company?
A good Liabilities-to-Assets depends on the Manufacturing - Apparel & Accessories industry context. However, Liabilities-to-Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Liabilities-to-Assets mean?
A high Liabilities-to-Assets can signal that a stock is expensive relative to its fundamentals. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on Ping An Biomedical Co and its competitors. Ping An Biomedical Co's current Liabilities-to-Assets is 0.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ping An Biomedical Co stock overvalued right now?
Ping An Biomedical Co (PASW) has a current Liabilities-to-Assets of 0.34. The current Liabilities-to-Assets is 0.34. Ping An Biomedical Co's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Liabilities-to-Assets calculated?
Liabilities-to-Assets is calculated from a company's financial statements. For Ping An Biomedical Co (PASW), the current Liabilities-to-Assets is 0.34 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ping An Biomedical Co Business Description

Address Tai Nan West Street, 1002-1008, 22nd Floor, China United Plaza, Cheung Sha Wan, Kowloon, Hong Kong, HKG
Ping An Biomedical Co Ltd formerly Majestic Ideal Holdings Ltd is a Cayman Islands-based holding company, conducting operations through its PRC subsidiary, NewBrand. The group is a provider of SCM services in the apparel industry, offering solutions for a broad range of yarn products, textiles, and finished garments. Its service offerings encompass every key aspect of the supply chain of textile products, such as market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The group has two reportable segments, yarns and finished garments. The majority of its revenue is generated from the sale of yarns, including pure cashmere and cashmere-mix yarn, merino wool, cotton, and fancy yarn.
17GF Score

Get the complete analysis for PASW

Liabilities-to-Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.12
Price